CTLA4 and neoplasm: Addition of anti‐CTLA‐4 antibodies to ILP‐TNF/Mel/SM led to a significant increase of T helper cells and also caused a reduction of intra‐tumoural CD3+CD4+Foxp3+ regulatory T cells (Fig 5C and D).